SypeStype
12-20-2022, 03:21 AM
In this procedure, an rpsL kanamycin marker was first inserted into the site of modification by selecting for kanamycin resistance and subsequently replaced with a luciferase cassette by selecting against streptomycin sensitivity Supplementary Figure S1, resulting in precise modifications without any unwanted sequences ivermectine 6mg ([Only registered and activated users can see links]) 2000; 60 1426 1433